Phibro Animal Health reported $163.88M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Align Technology ALGN:US USD 283.81M 12.64M
Ani Pharmaceuticals ANIP:US USD 32.89M 2.4M
Aurora Cannabis Inc ACB:CN CAD 72.09M 372K
Bristol Myers Squibb BMY:US USD 2.52B 167M
Canopy Growth Corp WEED:CN CAD 114.04M 2.53M
Corcept Therapeutics CORT:US USD 1.34M 23K
Depomed DEPO:US USD 4.01M 219K
Eli Lilly And LLY:US USD 1.55B 31M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Henry Schein HSIC:US USD 2.15B 68M
Idexx Laboratories IDXX:US USD 335.04M 11.48M
Knight Therapeutics Inc GUD:CN CAD 41.88M 4.35M
Lannett LCI:US USD 66.62M 4.14M
Merk MRK:US USD 3.36B 519M
Nektar Therapeutics NKTR:US USD 4.97M 143K
Pacira Pharmaceuticals PCRX:US USD 50.68M 51K
Patterson Companies PDCO:US USD 1.3B 86.98M
Phibro Animal Health PAHC:US USD 163.88M 12.97M
Prestige Brands PBH:US USD 125.12M 3.14M
Supernus Pharmaceuticals SUPN:US USD 25.88M 5.42M
Teva Pharmaceutical Industries TEVA:US USD 1.88B 73M
Zoetis ZTS:US USD 606M 14M